1. Department of Pharmacology, Dutch Migraine Research Group and Cardiovascular Research Institute ‘COEUR’, Erasmus University Medical Centre Rotterdam, Rotterdam, The Netherlands and
2. Centre de Recherche Pierre Fabre, Division of Cardiovascular Diseases, Castres, France